Obio Technology Corp., Ltd.

established in 2013, obio technology leads the way in gene and cell therapy as a pioneering cro and cdmo. our expertise spans vectorology studies, functional genomics, pd, ad, gmp production, as well as ind-enabling cmc and clinical and commercial manufacturing, provides comprehensive solutions internationally and tailored services for your needs. 🧬 gmp production: state-of-the-art 77,000 m2(830,000 ft 2) facility for global supply. 🧬 we specialize in vectorology studies, functional genomics, pd and ad, ensuring investigational new drug (ind) readiness and supporting all phases of clinical and commercial manufacturing. 🧬 from laboratory to clinic, we continuously advance your products, positively impacting populations worldwide. 🧬 our unwavering commitment ensures the delivery of high quality cdmo services across the preclinical, ind, clinical, and commercial stages. 🧬our expertise spans plasmids, mrna, aav, lvv, ad viral vectors, cell therapy, car-t, nk, treg, ipscs,